Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with XFOR: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
XFOR
X4 Pharmaceuticals, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
XFOR
X4 Pharmaceuticals, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
XFOR: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only XFOR
4
—
Genzyme Corporation ("Genzyme")
unlisted
supplier
—
Abbisko Therapeutics Co. Ltd. ("Abbisko")
unlisted
customer
—
Norgine Pharma UK Ltd. ("Norgine")
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Taiba Middle East Fz LLC ("taiba rare")
unlisted
customer
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
XFOR, dashed
AMGN
Amgen Inc
Change
478.34
▲
+3.70%
· post 480.00
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
XFOR
X4 Pharmaceuticals, Inc
Change
3.23
▲
+1.76%
· post 3.13
Closed
Nov 4 '26
Mkt cap
$321.2M
Revenue
$3M
Q3 FY26
Revenue
$35M
FY25
vs
Compare
Closed
Nov 4 '26
AMGN
Amgen Inc
vs
XFOR
X4 Pharmaceuticals, Inc
478.34
▲
+3.70%
post 480.00
Price
3.23
▲
+1.76%
post 3.13
$258.8B
Mkt cap
$321.2M
Q3 FY26
$10.4B
Revenue
$3M
Q3 FY26
FY25
$36.8B
Revenue
$35M
FY25
Change
Change
AMGN
478.34
▲
+3.70%
vs
XFOR
3.23
▲
+1.76%
Closed
Nov 4 '26